KRAS and serous adenocarcinoma: Although TP53 mutations are predominant in high-grade serous carcinoma and are the most common pathological type of epithelial ovarian cancer, KRAS mutations are more common in low-grade serous carcinoma and endometriosis-driven pathological types (clear cell or endometrioid carcinoma).